Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene
Related Experiment Video
Updated: Aug 8, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Luca Monaldini1, Rosanna Asselta, Stefano Duga
1Department of Biology and Genetics for Medical Sciences, University of Milan, Milan, Italy. stefano.duga@unimi.it
Background And Objectives:
Afibrinogenemia and hypofibrinogenemia are rare inherited coagulation disorders characterized by hemorrhagic manifestations of variable entity and by plasma fibrinogen deficiency. So far, 57 mutations have been associated with these disorders, and 18 of these are missense mutations. The aim of this study was to characterize the molecular mechanism underlying severe hypofibrinogenemia in a proband from India.
Design And Methods:
The mutational screening was accomplished by DNA sequencing of the three fibrinogen genes. The mutant protein was expressed in COS-1 cells, and intracellular and secreted mutant fibrinogen was analyzed by means of pulse-chase experiments.
Results:
A novel homozygous G-->A transition in exon 8 (nucleotide position 8017) was found in the proband's fibrinogen Bbeta-chain gene. The resulting G434D missense mutation (fibrinogen Mumbai) involves a highly conserved amino acid residue, located in the C-terminal globular D domain. In vitro expression experiments demonstrated intracellular retention of the mutant fibrinogen and marked reduction of its secretion.
Interpretation And Conclusions:
The G434D substitution causes severe hypofibrinogenemia by impairing fibrinogen secretion. Expression data confirm the importance of Bbeta-chain D domain folding in the intracellular processing of fibrinogen.
Insights
A novel G434D mutation in the fibrinogen Bbeta-chain gene causes severe hypofibrinogenemia by impairing fibrinogen secretion. This finding highlights the critical role of Bbeta-chain D domain folding in fibrinogen processing.
Area of Science:
- Hematology
- Molecular Genetics
- Biochemistry
Background:
- Afibrinogenemia and hypofibrinogenemia are rare inherited bleeding disorders.
- Characterized by low plasma fibrinogen levels and variable bleeding severity.
- 18 missense mutations are known, with 57 total mutations identified.
Observation:
- A novel homozygous G-->A transition in exon 8 of the fibrinogen Bbeta-chain gene was identified in an Indian proband.
- This resulted in a G434D missense mutation (fibrinogen Mumbai) in a conserved C-terminal D domain residue.
- In vitro studies showed intracellular retention and reduced secretion of the mutant fibrinogen.
Findings:
- The G434D substitution impairs fibrinogen secretion.
- Intracellular retention of fibrinogen is a key mechanism.
- This mutation leads to severe hypofibrinogenemia.
Implications:
- Confirms the importance of Bbeta-chain D domain folding for proper intracellular fibrinogen processing.
- Provides insight into the molecular mechanisms of hypofibrinogenemia.
- Contributes to understanding rare inherited coagulation disorders.
Related Concept Videos
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Intracellular Signaling Affects Focal Adhesions
Some...
